Opponent process model and psychostimulant addiction

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 3, 1997, Pages 513-521

  Koob, George F ^a   Caine, S Barak ^a   Parsons, Loren ^a   Markou, Athina ^a   Weiss, Friedbert ^a  

^a Division of Psychopharmacology   (United States)

Author keywords

Drug dependence; Drug withdrawal; Opponent process; Psychostimulants

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE; DOPAMINE RECEPTOR; SEROTONIN;

ADAPTATION; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR; BRAIN DEPTH STIMULATION; BRAIN REGION; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; HUMAN; MOTIVATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REINFORCEMENT; STRESS;

ANIMALS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MODELS, PSYCHOLOGICAL; OPIOID-RELATED DISORDERS; REINFORCEMENT (PSYCHOLOGY);

EID: 0030742522     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00438-8     Document Type: Article

References (66)

1. Amalric M., Berhow M., Polis I., Koob G. F. Selective effects of low-dose D2 dopamine receptor antagonism in a reaction time task in rats. Neuropsychopharmacology. 8:1992;195-200.
2. Amalric M., Koob G. F. Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Arbuthnott G. W., Emson P. C. Chemical signalling in the basal ganglia. 1993;209-226 Elsevier Science Publishers, B.V, Amsterdam.
3. American Psychiatric Association: Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 1995.
4. Baldwin H. A., Britton K. T., Koob G. F. Behavioral effects of corticotropin-releasing factor. Pfaff D. W., Ganten D. Behavioural aspects of neuroendocrinology. 1990;1-14 Springer-Verlag, New York.
5. Bergman J., Kamien J. B., Spealman R. D. Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonist. Behav. Pharmacol. 1:1990;355-363.
6. Britton D. R., Curzon P., Mackenzie R. G., Kebabian J. W., Williams J. E. G., Kerkman D. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39:1991;911-915.
7. Brog J. S., Salyapongse A., Deutch A. Y., Zahm D. S. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum. Immunohistochemical detection of retrogradely transported fluro-gold J. Comp. Neurol. 338:1993;255-278.
8. Caine S. B., Heinrichs S. C., Coffin V. L., Koob G. F. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692:1995;47-56.
9. Caine S. B., Koob G. F. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science. 260:1993;1814-1816.
10. Caine S. B., Koob G. F. Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. J. Exp. Anal. Behav. 61:1994;213-221.
11. 2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270:1994;209-218.
12. Caine S. B., Koob G. F. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav. Pharmacol. 6:1995;333-347.
13. Carroll M. E., Lac S. T. Cocaine withdrawal produces behavioral disruptions in rats. Life Sci. 40:1987;2183-2190.
14. Collier H. O. J. Cellular site of opiate dependence. Nature. 283:1980;625-629.
15. Davis W. M., Smith S. G. Conditioned reinforcement as a measure of the rewarding properties of drugs. Bozarth M. A. Methods of assessing the reinforcing properties of abused drugs. 1987;199-210 Springer-Verlag, New York.
16. deWit H., Wise R.A. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine and phenoxybenzamine. Can. J. Psychol. 31:1977;195-203.
17. Diaz J., Lévesque D., Lammers C. H., Griffon N., Martres M.-P., Schwartz J.-C., Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience. 65:1995;731-745.
18. Epping-Jordan M., Markou A., Koob G. F. D-1 receptor antagonist injected into the bed nucleus of the stria termalis antagonizes cocaine self-administration in the rat. Neurosci. Abstr. 21:1995;719.
19. Ettenberg A., Pettit H. O., Bloom F. E., Koob G. F. Heroin and cocaine intravenous self-administration in rats. Mediation by separate neural systems Psychopharmacology. 78:1982;204-209.
20. Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry. 43:1986;107-113.
21. Harris G. C., Aston-Jones G. β-Adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology. 113:1993;131-136.
22. Himmelsbach, C. K.: Symposium: Can the euphoric, analgetic, and physical dependence effects of drugs be separated? IV. With reference to physical dependence. Fed. Proc. 2:201-203; 1943.
23. Hubner C. B., Moreton J. E. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology. 105:1991;151-156.
24. Kleven M. S., Woolverton W. L. Effects of continuous infusions of SCH 23390 on cocaine or food-maintained behavior in rhesus monkeys. Behav. Pharmacol. 1:1990;365-373.
25. Koob G. F. Dopamine, addiction and reward. Semin. Neurosci. 4:1992;139-148.
26. Koob G. F. Animal models of drug addiction. Bloom F. E., Kupfer D. J. Psychopharmacology. The fourth generation of progress:1995;759-772 Raven Press, New York.
27. Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
28. Koob G. F., Heinrichs S. C., Menzaghi F., Pich E. M., Britton K. T. Corticotropin releasing factor, stress and behavior. Semin. Neurosci. 6:1994;221-229.
29. Koob G. F., Le H. T., Creese I. D-1 receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320.
30. Kornetsky C., Bain G. Biobehavioral bases of the reinforcing properties of opiate drugs. Ann. N.Y. Acad. Sci. 398:1982;241-259.
31. Kornetsky C., Esposito R. U. Reward and detection thresholds for brain stimulation. Dissociative effects of cocaine Brain Res. 209:1981;496-500.
32. Leith N. J., Barrett R. J. Amphetamine and the reward system. Evidence for tolerance and post-drug depression Psychopharmacologia. 46:1976;19-25.
33. 3H]hydroxy-N,N,-di-N-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA. 89:1992;8155-8159.
34. Maldonado R., Robledo P., Chover A. J., Caine S. B., Koob G. F. D-1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol. Biochem. Behav. 45:1993;239-242.
35. Markou A., Hauger R., Koob G. F. Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacology. 109:1992;305-314.
36. Markou A., Koob G. F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology. 4:1991;17-26.
37. Markou A., Koob G. F. Construct validity of a self-stimulation threshold paradigm. Effects of reward and performance manipulations Physiol. Behav. 51:1991;111-119.
38. Markou A., Koob G.F. Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacology. 7:1992;213-224.
39. Markou A., Weiss F., Gold L. H., Caine S. B., Schulteis G., Koob G. F. Animal models of drug craving. Psychopharmacology. 112:1993;163-182.
40. Substance Abuse and Mental Health Services Administration: National Household Survey on Drug Abuse: Population estimates 1995. Washington, DC: Public Health Service, US Department of Health and Human Services; 1996.
41. 3 receptor stimulation enhances cocaine reinforcement. J. Neurochem. 67:1996;1078-1089.
42. Parsons L. H., Koob G. F. Weiss, F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine J. Pharmacol. Exp. Ther. 274:1995;1182-1191.
43. Parsons L. H., Smith A. D., Justice J. B. Jr. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse. 9:1991;60-65.
44. Pettit H. O., Justice J. B. Jr. Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res. 539:1991;94-102.
45. Pickens R. Thompson, T. Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size J. Pharmacol. Exp. Ther. 161:1968;122-129.
46. Robinson T. E., Berridge K. C. The neural basis of drug craving. An incentive-sensitization theory of addiction Brain Res. Rev. 18:1993;247-291.
47. Rossetti Z. L., Hmaidan Y., Gessa G. L. Marked inhibition of mesolimbic dopamine release. A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats Eur. J. Pharmacol. 221:1992;227-234.
48. Russell M. A. H. What is dependence? Edwards G., Russell M. A. H., Hawks D., MacCafferty M. Drugs and drug dependence. 1976;182-187 Saxon House/Lexington Books, Farnborough, England.
49. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., Telegdy G. Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats. Brain Res. 675:1995;89-97.
50. Self D. W., Stein L. The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res. 582:1992;349-352.
51. Siegel S. Evidence from rats that morphine tolerance is a learned response. J. Comp. Physiol. Psychol. 89:1975;489-506.
52. Siegel S. Pharmacological conditioning and drug effects. Goudie A. J., Emmett-Oglesby M. W. Psychoactive drugs. Tolerance and sensitization:1989;115-180 Humana Press, Clifton, NJ.
53. Sokoloff P., Giros B., Martres M.-P., Bouthenet M.-L., Schwartz J.-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
54. Solomon R. L. The opponent-process theory of acquired motivation. The affective dynamics of addiction Maser J. D., Seligman M. E. P. Psychopathology. Experimental models:1977;124-145 W. H. Freeman and Co, San Francisco.
55. Solomon R. L., Corbit J. D. An opponent-process theory of motivation. 1 Temporal dynamics of affect. Psychol. Rev. 81:1974;119-145.
56. Stein L. Self-stimulation of the brain and the central stimulant action of amphetamine. Fed. Proc. 23:1964;836-850.
57. Stewart J., DeWit H., Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol. Rev. 91:1984;251-268.
58. Weddington W. W., Brown B. S., Haertzen C. A., Hess J. M., Mahaffey J. R., Kolar A. F., Jaffee J. H. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am. J. Drug Alcohol Abuse. 17:1991;137-152.
59. Weiss F., Markou A., Lorang M. T., Koob G. F. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 593:1992;314-318.
60. Wikler A. Dynamics of drug dependence. Implications of a conditioning theory of research and treatment Arch. Gen. Psychiatry. 28:1973;611-616.
61. Wise R. A., Bozarth M. A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
62. Wood D. M., Lal H. Anxiogenic properties of cocaine withdrawal. Life Sci. 41:1987;1431-1436.
63. Woolverton W. L., Virus R. M. The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol. Biochem. Behav. 32:1989;691-697.
64. Yang X. M., Gorman A. L., Dunn A. J., Goeders N. E. Anxiogenic effects of acute and chronic cocaine administration. Neurochemical and behavioral studies Pharmacol. Biochem. Behav. 41:1992;643-650.
65. Yokel R. A., Wise R. A. Increased lever pressing for amphetamine after pimozide in rats. Implications for a dopamine theory of reward Science. 187:1975;547-549.
66. Richter R. M., Merlo-Pich E., Koob G. F., Weiss F. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neuroscience Letters. 187:1995;169-172.